Article
Biliopancreatic malignancy: screening the at risk patient with molecular markers.
Annals of oncology : official journal of the European Society for Medical Oncology - 1 Jan 1999
Caldas C
Abstract excerpt
Biliopancreatic malignancy is one of the leading causes of cancer death in the Western world. Defining at risk groups has been difficult. Diabetes mellitus and pancreatitis increase the risk of pancreatic carcinoma, and inflammatory bowel disease and associated sclerosing colangitis increase the risk of biliary tract malignancy. Pancreatic carcinoma has also been described in pedigrees with inherited cancer...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
